human sirt2 protein rsirt2 his6 (R&D Systems)
Structured Review

Human Sirt2 Protein Rsirt2 His6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+sirt2/Recombinant+Human+Sirtuin+2%2FSIRT2+Protein%2C+CF/pm39334926-61-26-30
Average 94 stars, based on 1 article reviews
Images
1) Product Images from "Sirt2 Regulates Liver Metabolism in a Sex-Specific Manner."
Article Title: Sirt2 Regulates Liver Metabolism in a Sex-Specific Manner.
Journal: Biomolecules
doi: 10.3390/biom14091160
Figure Legend Snippet: Figure 1. (a) Mass spectrometry was used to quantify acetylated peptides from male Sirt2+/+ (WT) and Sirt2−/−(KO) livers. Peptides with significant changes in acetylation are rendered in red. Blue lines indicate the mean log2 fold-change. A total of 2452 acetylated peptides were quantified. The mean acetylation level significantly increased in 317 peptides (p < 0.01, FC > 1.5) due to Sirt2 ablation. (b) Mass spectrometry was used to quantify acetylated peptides from female Sirt2+/+ and Sirt2−/− livers. There was no appreciable change in acetylation levels across putative Sirt2-targets. (c) Volcano plot of Sirt2+/+ female to male ratios at each of the 2452 putative Sirt2 targets, expressed as Log2 FC. (d) Volcano plot of Sirt2−/−female to male ratios at each of the 2452 putative Sirt2 targets, expressed as Log2 FC. (e) The mean Log2 FC in Sirt2+/+ female/male acetylation was 4.2; the mean Log2 FC in Sirt2−/−female/male acetylation was 1.3. Quantification and comparison of the Log2 FC ratios using a Student’s two-sided t-test showed that Sirt2−/−males had significant decrease in hyperacetylation in 2452 putative sites compared to wild type counterparts (p < 0.0001). (f) Immunoblotting for Sirt2 in livers from wild type mice indicated no sex difference in the expression of the Sirt2 protein. Note that there are multiple bands due to multiple isoforms of Sirt2. **** p < 0.0001 by Student’s two-sided t-test.
Techniques Used: Mass Spectrometry, Comparison, Western Blot, Expressing
Figure Legend Snippet: Figure 2. (a) The 306 putative Sirt2 target sites mapped to proteins spread across multiple cellular compartments but were most abundant in the mitochondria and cytosol. (b) A plot of the Log2 ratio (FC > 1.5) of Sirt2−/−vs. Sirt2+/+ by cellular compartment revealed that the mitochondria and cytosol had the largest FCs in lysine acetylation. (c) The Log2 Ratio of putative mitochondrial Sirt2 targets from this study was compared to known Sirt3 targets within the mitochondria. Of the 140 Sirt2 targets represented in this plot, 19% are also Sirt3 targets. (d) Preparations of Sirt2+/+ nuclear and cytosolic fractions show that Sirt2 is present in both compartments, confirmed with the cytosolic marker α-tubulin and the nuclear marker, Lamin A/C (1 and 2 denote matched, replicate samples). Sirt2 is present in both compartments, confirming acetylomics data. (e) Sirt2 was not detected in mitochondria prepared from Sirt2+/+ hepatic tissue lysates (N = 3). 1–3 denotes replicate samples. (f) Sirt2 was not detected in peroxisomes prepared from Sirt2+/+ hepatic tissue lysates (N = 3). 1–3 denotes replicate samples. (g) The ultrapure subcellular fractionation technique used completely separated mitochondria and peroxisomes, confirmed with the peroxisomal marker, ACOX1, and the mitochondrial marker, TIMM23 (N = 3). 1–3 denotes matched, replicate samples. Membranes exposed at the same time, cropped for clarity.
Techniques Used: Marker, Fractionation
Figure Legend Snippet: Figure 3. (a,b) Total body weight and lean body mass were the same between Sirt2−/−(N = 11) and Sirt2+/+ (N = 8) males, but Sirt2−/−males had significantly lower fat mass compared to Sirt2+/+ males (p < 0.05). (b) Total body weight, fat mass, and lean mass were not significantly different between Sirt2−/−(N = 6) and Sirt2+/+ females (N = 8). Body composition was calculated for each mouse by dividing fat mass by lean mass. Only Sirt2−/−males had a significantly reduced fat/lean mass body composition (p < 0.001) compared to controls; female Sirt2−/−did not. (c) Blood glucose levels in Sirt2−/−vs. Sirt2+/+ males or females in both a fed and fasted state. In a fed state, there was no difference in blood glucose levels between Sirt2−/−and Sirt2+/+ in either males (N = 8) or females (N = 8). Upon fasting, only Sirt2−/−males had significantly reduced blood glucose levels (N = 8; p < 0.05) while Sirt2−/−females showed no significant reduction compared to controls (N = 8). (d) H&E staining of Sirt2−/−vs. Sirt2+/+ livers indicated no obvious morphological changes or tissue damage (N = 4). (e) Male Sirt2−/−mice (N = 3) had significantly less triglycerides in hepatic tissue compared to Sirt2+/+ males (N = 3; p < 0.05). Comparisons made with a Student’s nonparametric t-test; * p < 0.05, *** p < 0.001.
Techniques Used: Staining
Figure Legend Snippet: Figure 4. (a) Sirt2−/−and Sirt2+/+ males ran the same distance (N = 5) before reaching exhaustion. (b) Blood glucose levels were normal prior to the treadmill assay in male Sirt2−/−and Sirt2+/+ mice. Upon exhaustion, male Sirt2−/−mice (N = 5) had significantly lower blood glucose levels than Sirt2+/+ counterparts (N = 5; p < 0.01). (c) Sirt2−/−females (N = 6) ran significantly further than Sirt2+/+ females (N = 7; p < 0.005) before reaching exhaustion. (d) There was no significant difference in blood glucose levels between Sirt2−/−(N = 6) and Sirt2+/+ females (N = 7) post-exhaustion. Comparisons were made using a Student’s nonparametric t-test; ns = no difference; ** p < 0.01.
Techniques Used:
Figure Legend Snippet: Figure 5. (a) Male Sirt2−/−mice had a blunted response to a bolus lactate injection, with significantly decreased glucose production 15-min post-injection (N = 5; p < 0.05). (b) Sirt2−/−females had a
Techniques Used: Injection
Figure Legend Snippet: Figure 6. Schematic of glycolytic enzymes (red) and gluconeogenic enzymes (purple) that contain putative Sirt2 targets. Each significantly altered residue (p < 0.01; FC > 1.5) is identified with FC reported. Non-targets are in blue.
Techniques Used: Residue
Figure Legend Snippet: Figure 7. (a) Hepatocytes isolated from a Sirt2−/−liver showed reduced OCR compared to Sirt2+/+ hepatocytes during a mitochondrial stress test using a Seahorse Extracellular Flux Analyzer (p < 0.005). (b) Hepatocytes isolated from Sirt2−/−liver showed significantly reduced OCR compared to Sirt2+/+
Techniques Used: Isolation
Related Articles
Recombinant:Article Title: Facile chemoenzymatic synthesis of a novel stable mimic of NAD + †The X-ray structure of S-NAD + with human CD38 is deposited in Protein Data Bank ( https://www.rcsb.org ) (PDB ID: 6EDR ). ‡Electronic supplementary information (ESI) available: Experimental procedures, and supplementary figures, table, and data. See DOI: 10.1039/c8sc03899f Article Snippet: HPLC analysis was performed with a semipreparative C18 Kinetex column (5 μm, 100 Å, 150×10.0 mm, from Phenomenex Inc, Torrance, CA) using following method: mobile phase A: 0.1% formic acid (aq); mobile phase B: 0.1% formic acid in methanol; flow rate: 2.0 ml/min; 0-2 min: 0-4% B, 2-4 min: 4-10% B; 4-6 min: 10-20% B; 6-9 min: 20% B; 9-12 min: 20-50% B; and 12-14 min: 50-0% B. Substrate activity of S-NAD+ for human sirtuins 2 (SIRT2). .. Article Title: A ribose-functionalized NAD + with unexpected high activity and selectivity for protein poly-ADP-ribosylation Article Snippet: .. 0.5 mM NAD + or 6 was incubated with 0.25 mM acetylated peptide substrate Ac-Arg-Gly-Lys(Ac)-AMC (R&D System, MN) and 45.4 nM Article Title: A ribose-functionalized NAD + with unexpected high activity and selectivity for protein poly-ADP-ribosylation. Article Snippet: .. 0.5mM NAD+ or 6 was incubated with 0.25 mM acetylated peptide substrate Ac-Arg-Gly-Lys(Ac)-AMC (R&D System, MN) and 45.4 nM Incubation:Article Title: A ribose-functionalized NAD + with unexpected high activity and selectivity for protein poly-ADP-ribosylation Article Snippet: .. 0.5 mM NAD + or 6 was incubated with 0.25 mM acetylated peptide substrate Ac-Arg-Gly-Lys(Ac)-AMC (R&D System, MN) and 45.4 nM Article Title: A ribose-functionalized NAD + with unexpected high activity and selectivity for protein poly-ADP-ribosylation. Article Snippet: .. 0.5mM NAD+ or 6 was incubated with 0.25 mM acetylated peptide substrate Ac-Arg-Gly-Lys(Ac)-AMC (R&D System, MN) and 45.4 nM |
